we turn invisible into visible
by identifying and measuring multiple viral strains in the exhaled air in near real time
Three layers of innovation in a box:
a cutting-edge virus detection device for rapid and accurate diagnostics with unmatched convenience
1. VAir Device
Enables the non-invasive detection of multiple respiratory viruses, such as SARS-CoV-2, respiratory syncytial virus and influenza strains, in exhaled air at the point of care.
2. VAir Intelligence
A powerful combination of specific antibody recognition and a highly sensitive measurement system. Provides unparalleled accuracy in identifying viral pathogens and detecting infections in their earliest stages.
3. VAir App
Intuitive dashboard showing historical data and real-time results. Monitoring of patient responses to previous infections enables more informed and personalised care decisions.
Why choose VAir?
By combining the high accuracy and reliability of molecular diagnostics with the portability and rapid analysis capabilities of point-of-care solutions, we are making diagnostics faster, more accessible and scalable, significantly reducing the burden on healthcare systems.
| Molecular diagnostics | Rapid diagnostic tests | VAir | |
|---|---|---|---|
| Analysis time | 4–24 h | 5–60 min | < 3 min |
| Sensitivity | > 90% | 28–80% | > 90% |
| Need for trained staff | Yes | Depends on the type of test | No |
| Reagents for each test | Yes | Yes | No |
| Cost per test (for > 1000 tests) | $40–$72 | $3–$31 | < $5 |
-
Our robust platforms require no single-use consumables or time-consuming maintenance
-
The modular design ensures adaptability for the detection of emerging viruses
-
Early diagnosis enables better prevention and more efficient treatment, reducing the spread of infections and improving patient outcomes
